European Archives - Page 77 of 992 - European Medical Journal

Youth-Onset Type 2 Diabetes: An Awakening Epidemic

THE RISING global prevalence of youth-onset Type 2 diabetes (Y-T2D) is a serious public health concern. With an aggressive clinical course…

EASD 2024 Abstract Highlights

NEW RESEARCH presented at EASD 2024 revealed that maternal Type 1 diabetes (T1D) provides long-term relative protection against the…

EASD 2024 Interview: Francesco Giorgino

I was fascinated by hormones from when I first learnt about hormones as molecules that can carry a signal from one tissue or cell to…

How to maximise your year-end medical affairs and marketing budget

In the final quarter of the year, how can pharmaceutical teams make their final budget decisions count?

Behind the Breakthroughs: Tackling Vasculitis and Emerging Inflammatory Diseases

In this episode, Jonathan is joined by John H. Stone, Professor of Medicine at Harvard Medical School and The Edward A. Fox Chair in Medicine at Massachusetts General Hospital

Methods for Detecting Pancreatic Neoplasms

A novel deep-learning method utilising endoscopic ultrasound images could significantly enhance the detection of pancreatic neuroendocrine neoplasms according to recent research

Handshake on a green background

Merck acquires Modifi Biosciences in $1.3bn cancer therapy deal

The acquisition strengthens Merck’s oncology portfolio as the company looks to off the expiration of the patent for pembrolizumab.

Can Helicobacter Pylori Screening Prevent Gastric Cancer?

A trial investigated the effects of adding Helicobacter pylori stool antigen testing to colon cancer screening on rates of gastric cancer incidence and mortality.

Epigenetic Test May Predict Immunotherapy Success in Multiple Myeloma

Researchers have made a significant discovery that could one day help tailor immunotherapy treatments for patients with multiple myeloma.

Researchers Reveal the Symptoms of Long COVID are Caused by Brainstem Damage

New research using advanced 7T MRI has uncovered microscopic abnormalities in the brainstem of long COVID patients, revealing inflammation up to 18 months post-infection